FLIXOTIDE EVOHALER 125 mcg / فليكسوتايد إيفوهيلر 125 ميكروجرام

Flixotide (Fluticasone propionate)

Presentation

Flixotide Evohaler is a pressurized metered-dose inhaler which delivers125mcg of fluticasone propionate per actuation. Each canister supplies 60 or 120actuations.

Therapeutic Indications

Fluticasone propionate given by inhalation offers prophylactic treatment for asthma.

Posology and Method of Administration:

Flixotide Evohaler is for oral inhalation use only. It should be taken regularly even when they are asymptomatic. The onset of the therapeutic effect is within 4to7 days.

Adults and children over 16years: 250 to 1,000 micrograms twice daily, usually as two twice daily inhalations.

Patient should be given a starting dose appropriate the severity of their disease.

Typical starting doses are:

Mild asthma: 100 to 250mcg twice daily.

Moderate asthma: 250 to 500 mcg twice daily.

Severe asthma: 500 to 1.000 mcg twice daily.

Administration of doses above 1000mcg (500mcg twice daily), should be via a spacer device to help reduce side-effects in the mouth and throat.

Contra-indications: Hypersensitivity to any ingredient of the preparation.

Side effects

Yeast infection of the mouth (oral thrush)

Throat irritation

Hoarse voice

Unexpected narrowing of the airways (paradoxical bronchospasm)